Latisse™
An FDA-approved
lash
treatment
Get ready for a new innovation in lashes.
LATISSE™ (bimatoprost ophthalmic solution) 0.03% is
the first and only prescription treatment approved by the
FDA for inadequate or not having enough eyelashes, growing
them longer, fuller and darker.
LATISSE™ works effectively.
LATISSE™ makes lash growth possible because of its
active ingredient: bimatoprost. Although the precise mechanism
of action is not known, research suggests that the growth
of eyelashes occurs by increasing the percent of hairs in,
and the duration of, the anagen (or growth) phase. Lashes
can grow longer, thicker and darker because bimatoprost
can also prolong this growth phase.
Clinically proven results you can see over time.
LATISSE™ is easy to use, FDA approved and effective.
It's a once-a-day treatment you apply topically to the base
of your upper eyelashes. Patients in a clinical trial saw
results gradually over time (starting at 4 weeks with full
results after 16 weeks).
It's an innovation backed by research.
While LATISSE™ is a new treatment in eyelash growth,
it was developed through years of research by Allergan,
a pharmaceutical leader with over 60 years of expertise
in prescription eye care products.
For more information, visit the Latisse
website.
|